Tiziana Life Sciences Ltd. Common Shares (TLSA) is a publicly traded Healthcare sector company. As of May 19, 2026, TLSA trades at $1.38 with a market cap of $171.80M and a P/E ratio of 0.00. TLSA moved +2.96% today. Year to date, TLSA is -13.75%; over the trailing twelve months it is -6.76%. Its 52-week range spans $0.63 to $2.60. Rallies surfaces TLSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own TLSA include Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Tiziana Life Sciences Ltd. Common Shares.
| Metric | Value |
|---|---|
| Price | $1.38 |
| Market Cap | $171.80M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.60 |
| 52-Week Low | $0.63 |
| Volume | 243.75K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
TLSA analyst coverage data. Average price target: $0.00.